nafamostat has been researched along with Mitral Valve Insufficiency in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, K | 1 |
| Shirasaka, T | 1 |
| Kano, H | 1 |
| Okita, Y | 1 |
1 other study available for nafamostat and Mitral Valve Insufficiency
| Article | Year |
|---|---|
Mitral valve repair in active infective endocarditis with cerebral infarction.
Topics: Anticoagulants; Benzamidines; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Diffusion Magneti | 2013 |